Boeing Secures New Labor Contract With Former Spirit AeroSystems Employees 
Apple Forecasts Strong Revenue Growth as iPhone Demand Surges in China and India 
Samsung Electronics Posts Record Q4 2025 Profit as AI Chip Demand Soars 
Climate Adaptation at Home: How Irrigreen Makes Conservation Effortless 
Panama Supreme Court Voids CK Hutchison Port Concessions, Raising Geopolitical and Trade Concerns 
Apple Earnings Beat Expectations as iPhone Sales Surge to Four-Year High 
Apple Faces Margin Pressure as Memory Chip Prices Surge Amid AI Boom 
Federal Judge Signals Possible Dismissal of xAI Lawsuit Against OpenAI 
US Judge Rejects $2.36B Penalty Bid Against Google in Privacy Data Case 
Tesla Q4 Earnings Beat Expectations as Company Accelerates Shift Toward AI and Robotics 
Chinalco and Rio Tinto Acquire Controlling Stake in Brazil’s CBA for $903 Million 
Amazon Stock Dips as Reports Link Company to Potential $50B OpenAI Investment 
Panama Supreme Court Voids Hong Kong Firm’s Panama Canal Port Contracts Over Constitutional Violations 
SpaceX Updates Starlink Privacy Policy to Allow AI Training as xAI Merger Talks and IPO Loom 
CSPC Pharma and AstraZeneca Forge Multibillion-Dollar Partnership to Develop Long-Acting Peptide Drugs 
Microsoft AI Spending Surge Sparks Investor Jitters Despite Solid Azure Growth 
Meta Stock Surges After Q4 2025 Earnings Beat and Strong Q1 2026 Revenue Outlook Despite Higher Capex 
MIGDAL HA'EMEQ, Israel, May 25, 2017 -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients and medical foods, today announced that Mr. Erez Israeli, the Company’s Chief Executive Officer, will present at the Jefferies 2017 Global Healthcare Conference being held on June 6-9, 2017 at the Grand Hyatt New York in New York City.
Mr. Israeli is scheduled to present on Thursday, June 8, 2017 at 4:30 PM EDT. The presentation will take place in 7 Imperial. The presentation will be followed immediately by a breakout session at 5:00 PM EDT in the Booth Room.
Mr. Israeli and Mr. Oren Bryan, the Company’s Chief Financial Officer, will also be available to participate in one-to-one meetings with investors during the conference.
About Enzymotec Ltd.
Enzymotec is a leading global supplier of specialty lipid-based products and solutions. The Company develops, manufactures and markets innovative bio-active lipid ingredients, as well as final products, based on sophisticated processes and technologies.
Contact The Ruth Group Tram Bui / Alexander Lobo Phone: 646-536-7035 / 7037 [email protected] [email protected]
